drugset / Trial / NCT01694836
Depigoid Birch 5000 Longterm Study in Adults and Adolescents
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Specific immunotherapy for IgE mediated sensitization to birch pollen. Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified pollen extract of Betula alba (Birch) - versus placebo.
Timeline
- Start
- 2012-09-17
- Primary completion
- 2018-07-30
- Completion
- 2018-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Depigoid(R)Birch 5000 | Other / unclassified | 0.5 ml | Subcutaneous |